Roles of miR-182 in Intervertebral Disc Degeneration and its Potential Prognostic Value

Clinical Laboratory
|May 12, 2021
PubMed
Abstract

Insights

MicroRNA-182 (miR-182) is elevated in intervertebral disc degeneration (IDD) patients, negatively impacting prognosis. Inhibiting miR-182 promotes nucleus pulposus cell proliferation and reduces apoptosis, revealing its role in IDD progression.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Regenerative medicine

Background:

  • MicroRNAs are implicated in intervertebral disc degeneration (IDD) pathogenesis.
  • This study investigates the role of miR-182 in IDD progression and prognosis.

Purpose of the Study:

  • To evaluate the prognostic value of miR-182 in IDD.
  • To elucidate the underlying mechanism of miR-182 in nucleus pulposus (NP) cell function.

Main Methods:

  • Measured plasma miR-182 levels in 60 IDD patients and 60 controls.
  • Analyzed the correlation between miR-182 expression and IDD clinical features (JOA score).
  • Investigated miR-182 effects on NP cell proliferation and apoptosis in vitro using inhibitors and mimics.

Main Results:

  • Plasma miR-182 levels were significantly higher in IDD patients.
  • ROC analysis confirmed miR-182 as a diagnostic indicator for IDD.
  • Lower miR-182 expression correlated with better prognosis (higher JOA score).
  • miR-182 inhibition enhanced NP cell proliferation and decreased apoptosis; miR-182 mimics had opposite effects.
  • miR-182 modulated expression of apoptosis-related proteins (Bcl-2, Bax, Caspase-3).

Conclusions:

  • miR-182 is negatively correlated with IDD patient prognosis.
  • miR-182 influences NP cell proliferation and apoptosis in vitro.

Related Concept Videos